European Lung Cancer Working Party Clinical Practice Guidelines. Non-Small Cell Lung Cancer: III. Metastatic disease

摘要: The present guidelines on the management of advanced non-small cell lung cancer (NS CLC) were formulated by ELCWP in October 2006. They are designed to answer following twelve questions: 1) What benefits can be expected from chemotherapy and what treatment objectives? 2) active chemotherapeutic drugs for which efficacy has been shown? 3) Which most effective platinum-based regimens? 4) is indicated dosage cisplatin? 5) Can carboplatin substituted 6) optimal number cycles administered? 7) non-platinum based regimens platinum as first-line treatment? 8) Is there an indication sequential chemotherapy? 9) salvage should used that indication? 10) place targeted therapies? 11) a patient with brain metastases? 12) specific bone